AuraSense™
David Charlot, PhD, MSEng, is an accomplished entrepreneur and engineer with a strong background in bioengineering and technology development. Currently serving as the Chief Executive Officer and Founder of AuraSense™, David is pioneering the use of generative AI and automation for neurology assessments. Previously, as the CEO and Founder of CBio, David focused on microfluidics tools for gene therapy and pathogen detection. Throughout a diverse career, contributions at companies such as Ginkgo Bioworks and Biological Dynamics demonstrate expertise in automation, research, and development, while academic credentials include a PhD and MS in Bioengineering from UC San Diego, complemented by a Bachelor's degree in Physics from Delaware State University.
This person is not in any teams
AuraSense™
AuraSense is a startup pioneering novel neuroscience derived solutions to address emergency care challenges for people living with neurological disorders. Drawing from the founders' personal experiences living with neurological disorders, the company tackles the unmet need and frustration with the current system, which results in a $100 billion annual economic loss due to errors from poor subjective data. We bridge neurology care and emergency services using AI + specialized data capture enabling rapid response.